AU2003217877A1 - Eleutherosides as adjuncts for vaccines and immune modulation - Google Patents

Eleutherosides as adjuncts for vaccines and immune modulation

Info

Publication number
AU2003217877A1
AU2003217877A1 AU2003217877A AU2003217877A AU2003217877A1 AU 2003217877 A1 AU2003217877 A1 AU 2003217877A1 AU 2003217877 A AU2003217877 A AU 2003217877A AU 2003217877 A AU2003217877 A AU 2003217877A AU 2003217877 A1 AU2003217877 A1 AU 2003217877A1
Authority
AU
Australia
Prior art keywords
eleutherosides
adjuncts
vaccines
immune modulation
immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217877A
Other versions
AU2003217877A8 (en
Inventor
Vincent R. Bonagura
James R. Devoti
Herman W. Lance
John M. Mayhall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omega Pharmaceutical Inc
Original Assignee
Omega Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omega Pharmaceutical Inc filed Critical Omega Pharmaceutical Inc
Publication of AU2003217877A8 publication Critical patent/AU2003217877A8/en
Publication of AU2003217877A1 publication Critical patent/AU2003217877A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003217877A 2002-03-01 2003-03-03 Eleutherosides as adjuncts for vaccines and immune modulation Abandoned AU2003217877A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36078802P 2002-03-01 2002-03-01
US60/360,788 2002-03-01
PCT/US2003/006430 WO2003074000A2 (en) 2002-03-01 2003-03-03 Eleutherosides as adjuncts for vaccines and immune modulation

Publications (2)

Publication Number Publication Date
AU2003217877A8 AU2003217877A8 (en) 2003-09-16
AU2003217877A1 true AU2003217877A1 (en) 2003-09-16

Family

ID=27789026

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217877A Abandoned AU2003217877A1 (en) 2002-03-01 2003-03-03 Eleutherosides as adjuncts for vaccines and immune modulation

Country Status (2)

Country Link
AU (1) AU2003217877A1 (en)
WO (1) WO2003074000A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4953647B2 (en) * 2006-02-01 2012-06-13 学校法人近畿大学 Lignan compound and Helicobacter pylori motility inhibitor comprising the lignan compound as an active ingredient
WO2008128344A1 (en) * 2007-04-18 2008-10-30 The University Of British Columbia Small-molecule hepatitis c virus (hcv) ns3/4a serine protease inhibitors
CN103156874B (en) * 2012-12-19 2014-12-24 广东省中医院 Application of thorn wood bone glycosides B1 in antiviral drug of curing or preventing flu
CN111072737B (en) * 2019-12-31 2022-11-22 鲁东大学 Lignans compound and application thereof
JP2023515227A (en) * 2020-02-26 2023-04-12 上海科技大学 Use of disulfiram in anticoronavirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7018794A (en) * 1993-05-17 1994-12-12 Omega Pharmaceuticals, Inc. Methods for treating pathologies

Also Published As

Publication number Publication date
WO2003074000A3 (en) 2004-09-16
WO2003074000A2 (en) 2003-09-12
AU2003217877A8 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
HK1168046A1 (en) Yeast-based vaccines as immunotherapy
AU2003239932A1 (en) Tetravalent dengue vaccines
PL372937A1 (en) Viral antigens
GB0206359D0 (en) Viral antigens
IL175509A0 (en) Methods and agents for immune modulation
AU2003206862A1 (en) Hepatitis b vaccines
EP1572918A3 (en) Synthetic glyco-lipo-peptides as vaccines
EP1617872A4 (en) Methods and compositions for enhancing immune response
AU2003218099A1 (en) Modulation of the immune response through the manipulation of arginine levels
AU2003255787A1 (en) Modulation of immune function
AU2003243058A1 (en) Methods for using the cd163 pathway for modulating an immune response
SI1534330T1 (en) Whole bacterial cells as immune modulator
GB0220809D0 (en) Immune modulator
AU2003235799A1 (en) Modulation of iamt (pimt or pcmt) in immune system
AU2003234443A1 (en) Use of anti-cd1 antibodies for the modulation of immune responses
GB0212046D0 (en) Vaccines
AU2003217877A1 (en) Eleutherosides as adjuncts for vaccines and immune modulation
AU2003269268A1 (en) Modulation of immune function
AU2003302234A1 (en) Immune response associated proteins
AU2003225710A1 (en) Composition and method for enhancing immune response
AU2002248646A1 (en) Compositions and methods for modulating an immune response
AU2003900767A0 (en) Idiotypic vaccine
AU2003268230A1 (en) Immune response associated proteins
AU2003212475A1 (en) Immune response associated proteins
AU2003213167A1 (en) Sequence analysis of the tetravalent rotavirus vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase